A new multicolor bioluminescence imaging platform to investigate NF-κB activity and apoptosis in human breast cancer cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Mezzanotte, Laura ^a   An, Na ^a   Mol, Isabel M ^a   Löwik, Clemens W G M ^a   Kaijzel, Eric L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL ASSAY; CELL COUNT; CELL SELECTION; CELL VIABILITY; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; INVESTIGATIVE PROCEDURES; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MULTICOLOR BIOLUMINESCENCE IMAGING PLATFORM; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CHEMOPREVENTION; FEMALE; GENETIC VECTORS; HUMANS; IMAGING, THREE-DIMENSIONAL; LENTIVIRUS; LUMINESCENCE; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; TIME FACTORS; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898464336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085550     Document Type: Article

References (61)

1. Michelini E, Cevenini L, Mezzanotte L, Coppa A, Roda A (2010) Cell-based assays: fuelling drug discovery. Anal Bioanal Chem 398, 227-238.
2. Brasier AR, Ron D (1992) Luciferase reporter gene assay in mammalian cells. Methods Enzymol. 216, 386-97. (Pubitemid 23041084)
3. Wood KV (1990) Luc genes: introduction of colour into bioluminescence assays. J Biolumin Chemilumin. 5,107-114.
4. Contag CH, Jenkins D, Contag PR, Negrin RS (2000) Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2, 41-52. (Pubitemid 30123179)
5. De A, Lewis XZ, Gambhir SS (2003) Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol Ther. 7, 681-691. (Pubitemid 36626248)
6. Hosseinkhani S (2011) Molecular enigma of multicolor bioluminescence of firefly luciferase. Cell Mol Life Sci. 7, 1167-82.
7. Branchini BR, Ablamsky DM, Murtiashaw MH, Uzasci L, Fraga H, et al. (2007) Thermostable red and green light-producing firefly luciferase mutants for bioluminescent reporter applications. Anal Biochem 361, 253-262. (Pubitemid 46135385)
8. Nakajima Y, Kimura T, Sugata K, Enomoto T, Asakawa A, et al. (2005) Multicolor luciferase assay system: one-step monitoring of multiple gene expressions with a single substrate. Biotechniques 38, 891-894. (Pubitemid 41724847)
9. Michelini E, Cevenini L, Mezzanotte L, Ablamsky D, Southworth T, et al. (2008) Spectral-resolved gene technology for multiplexed bioluminescent cell-based assays and high-content screening. Anal Chem 80, 260-267. (Pubitemid 351448430)
10. Gammon ST, Leevy WM, Gross S, Gokel GW, Piwnica-Worms D (2006) Spectral unmixing of multicolored bioluminescence emitted from heterogeneous biological sources. Anal Chem 78, 1520-1527. (Pubitemid 43346289)
11. Mezzanotte L, Que I, Kaijzel EL, Branchini B, Roda A, et al. (2011) Sensitive dual color in vivo bioluminescence imaging using a new red codon optimized firefly luciferase and a green click beetle luciferase. PLoS ONE 6, e19277.
12. Wurdinger T, Badr C, Pike L, de Kleine R, Weissleder R, et al. (2008) A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods 5, 171-173. (Pubitemid 351181745)
13. Loening AM, Wu AM, Gambhir SS (2007) Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat Methods. 4, 641-643. (Pubitemid 47202475)
14. Yamagishi K, Enomoto T, Ohmiya Y (2006) Perfusion-culture-based secreted bioluminescence reporter assay in living cells. Anal Biochem 354, 15-21. (Pubitemid 43816382)
15. Fan F, Wood KV (2007) Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 5, 127-136. (Pubitemid 46581246)
16. Stell A, Belcredito S, Ramachandran B, Biserni A, Rando G, et al. (2007) Multimodality imaging: novel pharmacological applications of reporter systems. Q J Nucl Med Mol. Imaging 51, 127-138. (Pubitemid 47071622)
17. Liu M, Sakamaki T, Casimiro MC, Willmarth NE, Quong AA, et al. (2010) The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 70, 10464-10473.
18. Huber MA, Beug H, Wirth T (2004) Epithelial-mesenchymal transition: NFkappaB takes center stage. Cell Cycle 3, 1477-1480. (Pubitemid 40521393)
19. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 5, 749-759. (Pubitemid 41400849)
20. Prasad S, Ravindran J, Aggarwal BB (2010) NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem. 336, 25-37.
21. Lin Y, Bai L, Chen W, Xu S (2010) The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets. 14, 45-55.
22. Haefner B. (2006) Targeting NF-kappaB in anticancer adjunctive chemotherapy. Cancer Treat Res. 130, 219-245.
23. Katula KS, McCain JA, Radewicz AT (2005) Relative ability of dietary compounds to modulate nuclear factor-kappaB activity as assessed in a cell-based reporter system. J. Med. Food 8, 269-274. (Pubitemid 41008995)
24. Ralhan R, Pandey MK, Aggarwal BB (2009) Nuclear factor-kappa B links carcinogenic and chemopreventive agents. Front. Biosci.(School ed) 1, 45-60.
25. Castillo-Pichardo L, Martínez-Montemayor MM, Martínez JE, Wall KM, Cubano LA, et al. (2009) Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin. Exp. Metastasis 26, 505-516.
26. Jeong WS, Kim IW, Hu R, Kong AN (2004) Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm. Res. 21, 661-670. (Pubitemid 38457289)
27. Robbins D, Zhao Y (2011) Imaging NF-κB signaling in mice for screening anticancer drugs. Methods Mol. Biol. 716, 169-177.
28. Ashall L, Horton CA, Nelson DE, Paszek P, Harper CV, et al. (2009) Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription. Science 324, 242-246.
29. Bartfeld S, Hess S, Bauer B, Machuy N, Ogilvie LA, et al. (2010) High-throughput and single-cell imaging of NF-kappaB oscillations using monoclonal cell lines. BMC Cell Biol. 16, 11:21.
30. Gross S, and Piwnica-Worms D (2005) Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat Methods. 2, 607-614. (Pubitemid 41086852)
31. Carlsen H, Moskaug JØ, Fromm SH, Blomhoff R (2002). In vivo imaging of NF-kappa B activity. J Immunol. 1; 1441-6.
32. Scabini M, Stellari F, Cappella P, Rizzitano S, Texido G, et al. (2011) In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. Apoptosis. 16:198-207.
33. Carlotti F, Bazuine M, Kekarainen T, Seppen J, Pognonec P, et al. (2004) Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Mol. Ther. 9, 209-217. (Pubitemid 38256547)
34. Branchini BR, Ablamsky DM, Davis AL, Southworth TL, Butler B, et al. (2010) Red-emitting luciferases for bioluminescence reporter and imaging applications. Anal. Biochem. 396, 290-297.
35. Na IK, Markley JC, Tsai JJ, Yim NL, Beattie BJ, et al. (2010) Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo. Blood 116: e18-25.
36. Sethi G, Ahn KS, Pandey MK, Aggarwal BB (2007) Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood. 109, 2727-2735. (Pubitemid 46482064)
37. Kannaiyan R, Manu KA, Chen L, Li F, Rajendran P, et al. (2011) Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis 16, 1028-1041.
38. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, et al. (2005) Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int. J. Cancer. 116, 1004. (Pubitemid 41209211)
39. Moon DO, Kim MO, Kang SH, Choi YH, Kim GY (2009) Sulforaphane suppresses TNF-alpha-mediated activation of NF-kappaB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3. Cancer Lett. 274, 132-142.
40. Kallifatidis G, Rausch V, Baumann B, Apel A, Beckermann BM, et al. (2009) Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB induced anti-apoptotic signaling. Gut 58, 949-963.
41. Chiu TL, Su CC (2009) Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells. Int. J. Mol. Med. 23,469-475.
42. Kasperczyk H, La Ferla-Brühl K, Westhoff MA, Behrend L, Zwacka RM, et al. (2005) Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene 24, 6945-6956. (Pubitemid 41509417)
43. Jacobsen L, Calvin S, Lobenhofer E (2009) Transcriptional effects of transfection: the potential for misinterpretation of gene expression data generated from transiently transfected cells. Biotechniques 47,825.
44. Badr CE, Niers JM, Tjon-Kon-Fat LA, Noske DP, Wurdinger T, et al. (2009) Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. Mol. Imaging 8, 278-290.
45. Sung B, Park B, Yadav VR, Aggarwal BB (2010) Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. J. Biol. Chem. 285, 11498-11507.
46. Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, et al. (2003) Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J. 17, 2339-2341. (Pubitemid 39561486)
47. Nguyen TH, Mustafa FB, Pervaiz S, Ng FS, Lim LH (2008) ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells. Int. J. Oncol. 33, 81-92.
48. Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ, et al. (2006) Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol Cancer Ther. 5, 2034-2042. (Pubitemid 44336575)
49. Lampe JW. (2009) Sulforaphane: from chemoprevention to pancreatic cancer treatment? Gut 58, 900-902.
50. Li Y, Zhang T, Korkaya H, Liu S, Lee HF, et al. (2010) Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 16, 2580-2590.
51. Meeran SM, Patel SN, Li Y, Shukla S, Tollefsbol TO (2012) Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLoS ONE 7, e37748.
52. Zong H, Wang F, Fan QX, Wang LX (2012) Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol. Biol. Rep. 39, 4803-4808.
53. Kim SR, Park HJ, Bae YH, Ahn SC, Wee HJ, et al. (2012) Curcumin downregulates visfatin expression and inhibits breast cancer cell invasion. Endocrinology 153, 554-563.
54. Sun A, Lu YJ, Hu H, Shoji M, Liotta DC, et al.(2009) Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism. Bioorg Med Chem Lett. 19, 6627-31.
55. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin : problems and promises. Mol. Pharm. 4, 807-818.
56. Yallapu MM, Gupta BK, Jaggi M, Chauhan SC (2010) Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid. Interface. Sci. 351, 19-29.
57. Thamake SI, Raut SL, Gryczynski Z, Ranjan AP, Vishwanatha JK (2012) Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials 33, 7164-7173.
58. Maddox CB, Rasmussen L, White EL (2008) Adapting Cell-Based Assays to the High Throughput Screening Platform: Problems Encountered and Lessons Learned. JALA Charlottesv. Va. 13, 168-173.
59. Kwon H, Enomoto T, Shimogawara M, Yasuda K, Nakajima Y, et al. (2010) Bioluminescence imaging of dual gene expression at the single-cell level. Biotechniques 48, 460-462.
60. Liu HS, Jan MS, Chou CH, Chen PH, Ke NJ (1999) Is green fluorescent protein toxic to the living cells? Biochem. and Biophys.l Res. Comm.260, 712-717. (Pubitemid 29371116)
61. Shaner NC, Steinbach PA, Tsien RY (2005). A guide to choosing fluorescent proteins. Nat Methods. 2, 905-9. (Pubitemid 43108726)